Bioserve India Launches Advanced Stem Cell Products in India

Hyderabad, India – 22nd July 2024 – Bioserve India is excited to announce the launch of its advanced stem cell products in India. These new products from REPROCELL aims to support innovation in scientific research and drug development, supporting advancements in regenerative medicine and therapeutic discovery in Indian Market. The stem cell market is a rapidly growing industry that encompasses a wide range of services and products. Within the stem cell market, numerous industries are engaged in critical activities such as research and development manufacturing, and distribution of stem cell therapy products.

Key Features of Our Stem Cell Product Line:

  • Cell Culture and Stem Cell Products: Includes media, growth factors, specialized culture media, and tools for stem cell culture, differentiation, and disease modeling with iPSCs and ESCs.
  • Cell Reprogramming: Kits and small molecules for efficient iPSC generation from somatic cells.
  • 3D Cell Culture Systems: Scaffold-based platforms mimicking tissue architecture for enhanced drug screening and toxicity testing.
  • Cellular Assays and Services: Kits and custom services for assessing cell viability, proliferation, and metabolic activity.
  • Drug Discovery Services: REPROCELL Biopta offers preclinical services using human tissue technology to predict clinical outcomes, enhancing drug development success.
  • Biorepositories: Global repository with over 600,000 biospecimens, including tissues, blood, and genetic material, supporting diverse research needs.
  •  Research Tools: Antibodies, proteins, and genomic analysis kits for studying cellular mechanisms.

Bioserve.in is dedicated to deliver high-quality products and excellent customer support, ensuring researchers get reliable results. This launch is expected to boost stem cell research and therapy development in India, leading to new treatments and advancements in healthcare.

For more information about our stem cell products and to place orders, please visit [www.bioserve.in] 

About Bioserve.in

Bioserve.in is a leading provider of biotechnology and life sciences solutions, supporting scientific research and innovation. We offer a wide range of products and services to help researchers and clinicians achieve their goals and make important discoveries.  BioServe Biotechnologies India Pvt Ltd. Is a wholly owned subsidiary of REPROCELL, a company listed on the Tokyo Stock Exchange under Growth Market since 2013. REPROCELL, founded in 2002, is based in Yokohama, Japan and has laboratories in Beltsville, MD, USA, Glasgow, UK and Hyderabad, India to support global research efforts.